ZAI LAB LIMITED Prepaid Expense and Other Assets, Current
ZAI LAB LIMITED (ZLAB) had Prepaid Expense and Other Assets, Current of $32.63 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Prepaid Expense and Other Assets, Current $32.63M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $35.45M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $36.68M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $43.65M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $32.63M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $35.45M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $36.68M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $43.65M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $40.75M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $43.88M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $41.53M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $35.67M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $20.29M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $24.22M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $23.00M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $29.82M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $38.43M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $42.77M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $35.67M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $22.16M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $17.97M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $16.49M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $18.02M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $17.08M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $12.89M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $14.32M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $10.94M 10-K · filed 2022-03-01 | |
| 2020-06-30 | $7.68M 6-K · filed 2020-09-11 | |
| 2019-12-31 | $6.74M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $4.19M 6-K · filed 2020-01-21 | |
| 2019-01-01 | $5.61M 20-F · filed 2020-04-29 | $5.61M 6-K · filed 2020-01-21 |
| 2018-12-31 | $5.75M 20-F · filed 2020-04-29 | $5.75M 20-F · filed 2019-03-29 |
| 2017-12-31 | $954.51K 20-F · filed 2019-03-29 | |
| 2016-12-31 | $143.53K 20-F · filed 2018-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |